China Shineway Pharmaceutical Group Limited (FRA:C1S)

Market Cap	713.56M +13.4%
Revenue (ttm)	381.80M -17.0%
Net Income	115.67M +13.1%
EPS	0.15 +13.3%
Shares Out	n/a
PE Ratio	6.17
Forward PE	5.88
Dividend	0.07 (7.37%)
Ex-Dividend Date	May 4, 2026

Volume	n/a
Open	0.9200
Previous Close	0.9050
Day's Range	0.9200 - 0.9250
52-Week Range	0.8050 - 1.1000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 27, 2026

About FRA:C1S

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; and other dosage forms, including pills and tablets; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovas...

• Industry: Pharmaceutical Preparations
• Founded: 2002
• Employees: 2,822
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: C1S

Financial Performance

In 2025, FRA:C1S's revenue was 3.14 billion, a decrease of -17.01% compared to the previous year's 3.78 billion. Earnings were 949.95 million, an increase of 13.08%.

Financial numbers in CNY